29 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 30, 03:32 PM
Trimurthi Ltd.

BSE

  • 7.82 0.00 (0%)
  • Vol: 1000
  • BSE Code: 536565
  • PREV. CLOSE
    7.82
  • OPEN PRICE
    7.82
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Trimurthi Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
01-Feb-201713-Feb-2017 Quarterly Results
28-Oct-201605-Nov-2016 Quarterly Results
02-Aug-201608-Aug-2016
20-May-201630-May-2016 Audited Results
13-May-201624-May-2016 Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 24, 2016, inter alia, to transact the following items of business thereat: 1. Consider, approve and take on record the audited financial results (Consolidated and Standalone) for the quarter/year ended March 31, 2016. 2. To appoint consider fill the vacancy of women Director on the board caused by resignation of Ms. Priyanka Barve. & Audited Results
04-Feb-201612-Feb-2016 Quarterly Results
23-Dec-201529-Dec-2015 The Board of Directors of the Company will be held on December 29, 2015, inter alia, to transact the following items : 1. Consider change of name of the Company. 2. Consider change of objects of the Company subject to approval of Shareholders.
26-Oct-201502-Nov-2015Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 02, 2015, inter alia, to transact the following : 1. To review the performance of the Company. 2. Consider, approve and take on record the unaudited financial results (Consolidated and Standalone) for the half-year / quarter ended September 30, 2015. In this connection, as per the company's Code of conduct for prevention of insider trading, the trading window for dealing in the securities of the Company will remain closed for directors / officers / Designated Employees of the Company from October 25, 2015 to November 04, 2015 (both days inclusive).
04-Aug-201513-Aug-2015 Quarterly Results
13-May-201527-May-2015Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 27, 2015, inter alia, to transact the following items of business thereat: 1. To review the performance of the company. 2. Consider, approve and take on record the Audited financial results for the year ended and quarter ended March 31, 2015. 3. To take note of Disclosure of Interest of Directors. 4. To take note of declaration by independent directors. In this connection, as per the company's Code of conduct for prevention of insider trading, the trading window for dealing in the securities of the company will remain closed for directors/officers/Designated Employees of the company from May 12, 2015 to May 29, 2015(both days inclusive).
06-Apr-201511-Apr-2015 The Board of Directors of the Company will be held on April 11, 2015, to consider the redesignation of the Mr. Arun kumar Bhangadia as Executive Chairman (Director) of the Company and consider remuneration payable, terms and Conditions of appointment based on recommendations by the Remuneration Committee.
23-Jan-201507-Feb-2015 Quarterly Results & Trimurthi Drugs & Pharmaceuticals Ltd has informed that a meeting of the Board of Directors of the Company will be held on February 07, 2015, inter alia, to transact the following : 1. To review the performance of the Company. 2. Consider, approve and take on record the unaudited financial results for the quarter ended December 31, 2014.
29-Oct-201408-Nov-2014 Quarterly Results & The Board of Directors of the Company will be held on November 08, 2014, inter alia, to transact the following items of business thereat: 1. To review the performance of the Company. 2. Consider, approve and take on record the unaudited financial results for the quarter and half year ended September 30, 2014.
27-Aug-201404-Sep-2014 The Board of Directors of the Company will be held on September 04, 2014, inter alia, to transact the following: 1. To review the performance of the Company. 2. To take note of resignation of Independent Directors and consider appointment of Additional Directors to fill the vacancy. 3. To consider appointment of Company Secretary & Chief Financial Officer. 4. To approve the Directors Report for the Financial Year 2013-14 5. To fix the date of AGM and Book Closure.